Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Reducing Toxicity Associated with Teclistamab: The Role of Prophylactic Tocilizumab and Timing for Immunoglobulin Replacement in a National Cohort Study

  • By

  • Astrid Hundebøll Torpe

  • Jonathan Thorsen

  • Gustav Mathiasen

  • Katrine Fladeland Iversen

  • Sarah Farmer

  • Thomas Lund

  • Charlotte Toftmann Hansen

  • Lene Kongsgaard Nielsen

  • Nicolai Grønne Dahlager Jørgensen

  • Maja Ølholm Vase

  • Elena Manuela Teodorescu

  • Morten Salomo

  • Christina Wennerström

  • Tobias S. Slørdahl

  • Agoston Gyula Szabo

  • May 26, 2026

Share

Original Source(s)

Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort

  • by Astrid Hundebøll Torpe, Jonathan Thorsen, Gustav Mathiasen, Katrine Fladeland Iversen, Sarah Farmer, Thomas Lund, Charlotte Toftmann Hansen, Lene Kongsgaard Nielsen, Nicolai Grønne Dahlager Jørgensen, Maja Ølholm Vase, Elena Manuela Teodorescu, Morten Salomo, Christina Wennerström, Tobias S. Slørdahl, Agoston Gyula Szabo

  • May 26, 2026

Related Content

Prostate Cancer Treatments—Do The Dollars Create Value?

The evolution of RTOG and NRG Oncology CNS tumors clinical trials

Correction to: Anatomical and surgical factors associated with postoperative hydrocephalus after central neurocytoma resection: a large single-center cohort study